Cold Steel: Canadian Journal of Surgery Podcast

Canadian Journal of Surgery

The official podcast of the Canadian Journal of Surgery

  1. JAN 14 · BONUS

    Bonus Episode from EBRS Webinar: "The INSEMA Trial: Axillary Surgery in Breast Cancer & The SOUND Randomized Control Trial"

    This Evidence Based Reviews in Surgery (EBRS) webinar was filmed May 2025. This webinar was moderated by Dr. Alison Laws and Dr. Kerollos Wanis, and featured panelists Dr. Stephanie Wong, Dr. Sarah Knowles and Dr. Rebecca Warburton. In this EBRS webinar, we discussed Axillary Surgery in Breast Cancer--Primary Results of the INSEMA Trial (Reimer et al., 2024) & Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes (Gentilini et al., 2023). Links: Gentilini, O. D., Botteri, E., Sangalli, C., Galimberti, V., Porpiglia, M., Agresti, R., Luini, A., Viale, G., Cassano, E., Peradze, N., Toesca, A., Massari, G., Sacchini, V., Munzone, E., Leonardi, M. C., Cattadori, F., Di Micco, R., Esposito, E., Sgarella, A., Cattaneo, S., … SOUND Trial Group (2023). Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial. JAMA oncology, 9(11), 1557–1564. https://doi.org/10.1001/jamaoncol.2023.3759Reimer, T., Stachs, A., Veselinovic, K., Kühn, T., Heil, J., Polata, S., Marmé, F., Müller, T., Hildebrandt, G., Krug, D., Ataseven, B., Reitsamer, R., Ruth, S., Denkert, C., Bekes, I., Zahm, D. M., Thill, M., Golatta, M., Holtschmidt, J., Knauer, M., … Gerber, B. (2025). Axillary Surgery in Breast Cancer – Primary Results of the INSEMA Trial. The New England journal of medicine, 392(11), 1051–1064. https://doi.org/10.1056/NEJMoa2412063

    1h 5m
  2. E187 - Krista Goulding on Pelvic Sarcomas, 3D Printing, and What Patients Really Want

    12/23/2025

    E187 - Krista Goulding on Pelvic Sarcomas, 3D Printing, and What Patients Really Want

    The William Ersil Research day invited guest and moderator for 2025 was Dr. Krista Goulding.  Dr. Goulding is an Orthopedic Surgeon at Mayo Clinic Arizona, where she specializes in caring for patients with sarcomas and other cancerous and non-cancerous tumors of the musculoskeletal system.  Dr. Goulding’s expertise is in limb preservation surgery using innovative techniques (synthetic and bone transplants, 3D printed and patient-specific implants, joint replacement). Her goal is to cure cancer while preserving function and quality of life. She is involved in research on a national and international scale, and is currently researching ways to improving surgical, oncologic and health-related quality of life outcomes for patients with malignant bone and soft tissue cancers. In this “How I Built This” segment of the research day, we explored Dr. Goulding’s career. Links: What are the 2-year survivorship outcomes of custom hemipelvis reconstruction after hemipelvectomy and revision arthroplasty? The evolution of a custom ilium "monoflange". https://pubmed-ncbi-nlm-nih-gov.proxy.queensu.ca/36255157/Košir U, Denis-Larocque G, Tsimicalis A, Freeman C, Turcotte RE, Cury F, Alcindor T, Goulding K. Psychological functioning, coping styles and their relationship to appraisal of physical limitations following invasive surgical procedures for soft-tissue sarcoma: A qualitative study. J Surg Oncol. 2020 Jun;121(8):1266-1275. doi: 10.1002/jso.25915. Epub 2020 Mar 27. PMID: 32221986.

    30 min
  3. E186 - Adnan Alseidi on Rethinking Surgical Education

    11/18/2025

    E186 - Adnan Alseidi on Rethinking Surgical Education

    Surgery has never been more complicated. The variety of surgical approaches and the complexity of treatment continue to grow exponentially, yet in many institutions, surgical training has not really changed. Dr. Adnan Alseidi, our guest for this episode, is trying to change that.  Dr. Adnan Alseidi is a liver and pancreas surgeon at UCSF and is the associate dean of assessment, improvement, and accreditation. He recently gave the Langer lecture at the Canadian Surgical Forum in Montreal this year about surgical education and the path from novice to master. This episode was really a moment for us to ask all our burning questions about surgical education. What are the phases of mastery? Should we really be aiming for mastery? And how do we create trust between attending and trainees? We’d love to hear your thoughts and comments, so email us at podcast.cjs@gmail.com. Links: Medical school accreditation is outdated. WSJ. https://www.wsj.com/opinion/medical-school-accreditation-is-outdated-holds-back-innovation-nyu-98fe80bdhttps://www.canadiansurgeryforum.com/biographiesAn Integrative Model of Organizational Trust. Roger C. Mayer, James H. Davis, F. David Schoorman. The Academy of Management Review, Vol. 20, No. 3 (Jul., 1995), pp. 709-734 (26 pages). https://www.jstor.org/stable/258792Ericsson. https://share.google/bRhcSSC7sKKp9bX9bThe Five-Stage Model of Adult Skill Acquisition. Dreyfus model. https://share.google/2GSuypiGKExQMeMPXWicked problems! Horst W. J. Rittel & Melvin M. Webber . Dilemmas in a general theory of planningThe Book Of Joy: Lasting Happiness In A Changing World. Dalai Lama,Desmond Tutu,Douglas Carlton Abrams

    35 min
  4. E185 - Teresa Purzner on Developing a Cure for Pediatric Brain Tumors, Entrepreneurship, and Design-Thinking in Healthcare

    11/04/2025

    E185 - Teresa Purzner on Developing a Cure for Pediatric Brain Tumors, Entrepreneurship, and Design-Thinking in Healthcare

    Dr. Teresa Purzner MD PhD FRCSC is a clinician scientist neurosurgeon with a special interest in neuroncology and general neurosurgery.  She completed her residency training at the University of Toronto, and her PhD training at Stanford University.  Her lab, run jointly with her husband Dr. James Purzner, is focused on interdisciplinary approaches to identifying novel drug targets for brain cancer as well as the translation of promising new drug targets into human-ready therapeutics.  Her work has led to the identification of a critical new drug target in the brain tumor medulloblastoma – a discovery that she has since translated into a novel drug for both brain cancer and skin cancer, currently being tested in phase 1 and phase 2 clinical trials.  This work has resulted in her being named a Stanford Interdisciplinary Graduate fellow, Biox fellow and SPARK fellow, and has earned her both national and international recognition including the Annual Award of the American Academy of Neurological Surgery, the K.G. McKenzie prize for Basic Science Research, AANS Louise Eisenhardt Award and the Neurosurgery Research and Education Fellowship. She is a mom, an entrepreneur, and design-thinker, having created her own baby food company as well as redesigned the Integrated Brain Tumor Program.  Links: Integrated Brain Tumor Program: https://surgery.queensu.ca/administration/announcements/integrative-brain-tumor-program-achieving-best-class-patient-outcomeshttps://www.ibtp.ca/purzner-labhttps://www.theglobeandmail.com/business/economy/article-how-a-neurosurgeon-used-her-entrepreneurial-background-to-revamp-a/

    48 min

Ratings & Reviews

5
out of 5
4 Ratings

About

The official podcast of the Canadian Journal of Surgery